Why Non-Invasive Cardiovascular Diagnostics with CMAT Advantage Are the Future of Primary Care
1 | Primary Care Is Under Pressure to Detect Vascular Disease Earlier
- PAD prevalence is rising—current estimates hover near 20 million U.S. adults, yet half remain undiagnosed until symptomatic. ahajournals.org
- 2024 ACC/AHA guidelines call for broader use of non-invasive testing (ABI ± adjunctive waveforms) in diabetics, smokers, and adults ≥ 65 years. ahajournals.org
- Value-based contracts reward documented risk stratification, but manual Doppler workflows are slow and operator-dependent.
Take-home: Primary-care practices need a fast, reproducible way to screen PAD and autonomic dysfunction inside the standard visit length.
2 | How CMAT Advantage Expands Diagnostic Reach in 7 Minutes
Test Module | CPT Code | Clinical Insight | Evidence Edge |
ABI + Pulse-Volume Recording (PVR) | 93922 | Peripheral arterial disease | PVR boosts diagnostic sensitivity to 84 % in diabetics—11 points higher than ABI alone. mdpi.com |
Autonomic HR Variability | 95921 | Cardiovagal dysfunction (diabetes, long-COVID, chemo) | Covered under Medicare Article A54954. cms.gov |
Sudomotor Function | 95923 | Small-fiber neuropathy | Adds objective data often missed in monofilament exams. |
One device, one MA, one sitting—three established CPTs.
3 | Revenue Snapshot for Busy Family Practices
Running 10 tests/week (50 weeks) at 2025 Medicare national averages:
CPT | Reimbursement | Annual Gross |
93922 | $ 75 | $ 39 000 |
95921 | $ 110 | $ 57 200 |
95923 | $ 130 | $ 67 600 |
Total | — | $ 163 800 |
Most clinics recoup a financed CMAT Advantage inside 6–9 months, even after disposables.
4 | Why Non-Invasive Matters for Patient Experience & Quality Scores
- Comfort & Speed – Automated cuffs and skin pads replace gel probes; the full protocol adds < 3 minutes beyond routine vitals.
- Data-Driven Counseling – Color-coded PDF reports simplify shared-decision-making conversations.
- MIPS & HEDIS Friendly – Objective PAD and autonomic data feed preventive-care and cardiometabolic quality measures.
- Reducing Downstream Cost – Early detection prevents amputations and unplanned admissions—outcomes now tracked by many ACOs. pmc.ncbi.nlm.nih.gov
5 | Future-Proof Technology & AI Readiness
- Secure software-update downloads add new analytics modules without new hardware.
- HL7/XML output positions the device for AI-driven population health dashboards now emerging in cardiology. vitalsolution.com
- Cloud audit logs satisfy IDTF and payer documentation rules. cms.gov
6 | Implementation Roadmap—Fast, Low-Friction
Phase | Timeline | Milestones |
Staff Certify | Day 0–7 | 90-minute MA e-learning; competency badge issued. |
Workflow Pilot | Week 2 | Run five staff “test patients,” refine room flow. |
Go-Live | Week 3 | Add EHR flag for high-risk patients; start billing all three CPTs. |
Quarterly Review | Q1 | HealthWright specialist audits claims & missed CPTs. |
7 | Key Take-Aways for Primary-Care Leaders
- Guideline-Aligned: Meets 2024 ACC/AHA recommendations for PAD assessment.
- Triple-CPT Revenue: Elevates ancillary income without extra physician minutes.
- Patient-Centric: Non-invasive, fast, and education-friendly.
- AI-Ready: Structured data feeds future risk-prediction platforms.
Ready to Evaluate the CMAT Advantage?
- Download the ROI Calculator to gauge impact with your payer mix.
- Book a 30-minute live demo—see a triple-test run on de-identified patient data.
- Request our due-diligence kit (clinical papers, warranty, financing) for partner review.
HealthWright Technologies Inc designed the CMAT Advantage so that every primary-care clinic can deliver hospital-grade cardiovascular insight—profitably, sustainably, and without a single needle stick.